C-Rad
25.65 SEK
0.00 %
Less than 1K followers
CRAD B
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for C-Rad
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 205.4 | 221.6 | 261.2 | 301.3 | 424.6 | 469.0 | 441.9 |
| growth-% | 7.9 % | 17.9 % | 15.4 % | 40.9 % | 10.5 % | -5.8 % | |
| EBITDA | 11.4 | 26.1 | 45.7 | 31.9 | 66.4 | 79.9 | 55.3 |
| EBIT | -9.6 | 17.1 | 36.0 | 21.8 | 57.5 | 70.0 | 45.1 |
| Profit before taxes | -11.4 | 16.4 | 35.7 | 21.5 | 57.2 | 79.8 | 15.9 |
| Net income | -13.8 | 14.4 | 25.1 | 7.5 | 46.1 | 56.5 | 10.5 |
| EPS | -0.45 | 0.43 | 0.75 | 0.22 | 1.36 | 1.67 | 0.31 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
| Dividend ratio | -0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 32.3 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | 5.6 % | 11.8 % | 17.5 % | 10.6 % | 15.6 % | 17.0 % | 12.5 % |
| EBIT-% | -4.7 % | 7.7 % | 13.8 % | 7.2 % | 13.5 % | 14.9 % | 10.2 % |
| ROE | -16.6 % | 7.2 % | 10.9 % | 3.1 % | 16.4 % | 17.4 % | 3.0 % |
| ROI | -8.7 % | 5.3 % | 8.2 % | 2.2 % | 11.4 % | 11.5 % | 2.1 % |